Pan-cancer analyses reveal genomics and clinical characteristics of the melatonergic regulators in cancer

Biochemistry, Genetics and Molecular Biology

• Melatonin 54%
• MicroRNA 18%
• Circadian Rhythm 18%
• Expression Analysis 18%
• Survival 18%
• Signal Transduction 9%
• Cancer Cell 9%
• down Regulation 9%
• Apoptosis 9%
• Nested Gene 9%
• Secretion (Process) 9%
• Electric Potential 9%
• Cell Cycle 9%
• Data Base 9%
• DNA Damage Response 9%
• Mitogen-Activated Protein Kinase 9%
• Methylation 9%
• Metabolic Pathway 9%
• CYP2C19 9%
• Drug Sensitivity 9%
• Sample 9%
• Regulatory Mechanism 9%
• Messenger RNA 9%
• Sleep 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Malignant Neoplasm 100%
• Melatonin 54%
• microRNA 27%
• Survival 18%
• Neoplasm 9%
• Carcinogenesis 9%
• Messenger RNA 9%
• Hormone 9%
• DNA 9%
• Drug 9%
• CYP2C19 9%
• Tamsulosin 9%
• Cell Cycle 9%
• Apoptosis 9%

Neuroscience

• Melatonin 54%
• MicroRNA 27%
• Cell Line 9%
• Cell Signaling 9%
• Apoptosis 9%
• Cell Cycle 9%
• Circadian Rhythm 9%
• DNA Damage Response 9%
• Cytochrome P450 2C19 9%
• Methylation 9%
• Gene 9%
• PER3 9%
• Sleep 9%